Dose-ranging studies on liposomal amphotericin B (L-AMP-LRC-1) in the treatment of visceral leishmaniasis

Autor: Anil Pathare, B G Kirodian, A.K. Pandey, Thakur Cp, R.N. Kotwani, Bodhe Pv, N.A. Kshirsagar

Publikováno v: Transactions of the Royal Society of Tropical Medicine and Hygiene. 93(3)

Efficacy and tolerability of liposomal amphotericin B (L-AMP-LRC-1; developed in India by the Liposome Clinical Pharmacology Centre, Mumbai, and the Liposome Research Centre, New Delhi) were assessed in 63 patients suffering from visceral leishmanias

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1feab4105af2392e89c0593c3c50a51f
https://pubmed.ncbi.nlm.nih.gov/10492769

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Shirodhara: A psycho-physiological profile in healthy volunteers.

Autor: Dhuri KD; Department of Clinical Research, ICMR Advanced Centre of Reverse Pharmacology in Traditional Medicine, Medical Research Centre, Kasturba Health Society, Mumbai, India., Bodhe PV, Vaidya AB

Publikováno v: Journal of Ayurveda and integrative medicine [J Ayurveda Integr Med] 2013 Jan; Vol. 4 (1), pp. 40-4.

Open label, randomised, comparative phase III safety and efficacy study with conventional amphotericin B and liposomal amphotericin B in patients with systemic fungal infection.

Autor: Bodhe PV; Liposome Clinical Pharmacology Centre, Seth GS Medical College and KEM Hospital, Parel, Mumbai., Kotwani RN, Kirodian BG, Kshirsagar NA, Pandya SK

Publikováno v: The Journal of the Association of Physicians of India [J Assoc Physicians India] 2002 May; Vol. 50 (5), pp. 662-70.

Resurgence of malaria in Mumbai--is escalating chloroquine resistance a cause?

Autor: Garg MR; Dept of Pharmacology, KEM Hospital, Parel, Mumbai., Gogtay NJ, Kotwani RN, Bodhe PV, Kshirsagar NA

Publikováno v: The Journal of the Association of Physicians of India [J Assoc Physicians India] 1999 Apr; Vol. 47 (4), pp. 377-9.